{"id":3040,"date":"2020-07-13T13:48:45","date_gmt":"2020-07-13T17:48:45","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/hematology\/?page_id=3040"},"modified":"2025-12-11T12:26:48","modified_gmt":"2025-12-11T17:26:48","slug":"leukemia","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/hematology\/leukemia\/","title":{"rendered":"Malignant Hematology"},"content":{"rendered":"

 <\/p>\n

\"\"Vaishali Sanchorawala, MD<\/a><\/strong><\/span>
\nDirector, Autologous Stem Cell Transplant Program<\/em>
\n Director, Amyloidosis Center<\/em>
\nProfessor of Medicine
\nEducation<\/strong>: Seth G.S. Medical College, Bombay University, India (M.B.B.S., 1988)
\nResidency: <\/strong>University of Medicine and Dentistry of New Jersey, Newark, NJ (1991-1994)
\nFellowship: <\/strong>Boston University Medical Center, Boston, MA (1994-1997)
\nBoard Certification<\/strong>: Internal Medicine, Hematology, Oncology
\nSpecial Interests: <\/strong>AL Amyloidosis, Stem Cell Transplantation, Myeloma, Health Related Quality of life in AL amyloidosis, Clinical Trial<\/span>
\n <\/p>\n

\"\"Mark Sloan, MD<\/a><\/strong><\/span>
\nDirector of Fellowship Program<\/em>
\n<\/span>Associate Professor of Medicine
\nEducation<\/strong>: Yale University School of Medicine, New Haven, CT (MD, 2001)
\nResidency<\/strong>: Yale New Haven Hospital, New Haven, CT (2001-2004)
\nFellowship<\/strong>: Dana-Farber Cancer Institute and Massachusetts General Hospital, Boston MA (2005-2008)
\nBoard Certification<\/strong>: Internal Medicine, Hematology Oncology
\nSpecial Interests<\/strong>: <\/span>AL Amyloidosis, Lymphoma and Leukemia, Multiple Myeloma, Thrombosis and Hemostasis, Autologous Stem Cell Transplantation<\/span>
\n <\/p>\n

\"\"Adam Lerner, MD<\/a><\/strong><\/span>
\nCo-Director, Cutaneous Oncology Program<\/em>
\nProfessor of Medicine and Pathology<\/span>
\nEducation:<\/strong> Yale University School of Medicine, New Haven, CT (MD, 1983)
\nResidency:<\/strong> Boston City Hospital, Boston, MA (1984-1986)
\nFellowship:<\/strong> Dana-Farber Cancer Institute, Harvard Medical School, Boston MA (1988-1991)
\nBoard Certification<\/strong>: Internal Medicine, Medical Oncology
\nSpecial Interests:<\/strong> Lymphoma, Leukemia, Sarcoma, Skin cancer
\n <\/p>\n

\"\"<\/a>Fabio Petrocca, MD<\/a><\/span><\/strong>
\nDirector, Cellular Therapy Program<\/em>
\n<\/span>Assistant Professor of Medicine
\nEducation<\/strong>: University of Rome, Sapienza, Italy (MD, 2004)
\nTraining Program: <\/strong>University of Ferrara, Italy (2004-2008)
\nResearch Fellowship<\/strong>: Harvard Medical School and Boston Children’s Hospital (2008-2012)
\nSpecial Interests<\/strong>: Translational and clinical development of CAR T and TCR T cell therapies, Molecular mechanisms of tumor resistance to small molecule targeted agents and cell therapy, Identification and validation of novel cancer therapeutic targets<\/span>
\n <\/p>\n

\"\"<\/a> Raphael Szalat, MD<\/span><\/strong>
\nDirector, Multiple Myeloma Program<\/em>
\n<\/span>Assistant Professor of Medicine
\nEducation<\/strong>: Universite Pierre et Marie Curie Paris VI, Paris, France (MD, 1997-2004)
\nResidency<\/strong>: APHP-Assistance Publique des hospitaux de Paris, Paris, France (2004-2010)
\nClinical Fellowship<\/strong>: Saint-Louis Hospital, Paris, France (2010-2013)
\nFellowship<\/strong>: Boston Medical Center, Boston, MA (2018-2021)
\n<\/strong><\/strong>
\n <\/p>\n","protected":false},"excerpt":{"rendered":"

  Vaishali Sanchorawala, MD Director, Autologous Stem Cell Transplant Program Director, Amyloidosis Center Professor of Medicine Education: Seth G.S. Medical College, Bombay University, India (M.B.B.S., 1988) Residency: University of Medicine and Dentistry of New Jersey, Newark, NJ (1991-1994) Fellowship: Boston University Medical Center, Boston, MA (1994-1997) Board Certification: Internal Medicine, Hematology, Oncology Special Interests: AL […]<\/p>\n","protected":false},"author":6467,"featured_media":0,"parent":0,"menu_order":37,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/pages\/3040"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/users\/6467"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/comments?post=3040"}],"version-history":[{"count":33,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/pages\/3040\/revisions"}],"predecessor-version":[{"id":5990,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/pages\/3040\/revisions\/5990"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/media?parent=3040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}